BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1160622)

  • 1. Combination chemotherapy in the treatment of advanced Hodgkin's disease.
    Borromeo VD; Wilner FR; Axelrod AR; Schneider JR
    Mich Med; 1975 Sep; 74(27):557-63. PubMed ID: 1160622
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combination chemotherapy (MOPP) in 60 patients with Hodgkin's disease (five years results) (author's transl)].
    Lauria F; Baccarani M; Barbieri E; Fiacchini M; Gobbi M; Tura S; Baccarani M
    Haematologica; 1975 Mar; 60(1):73-84. PubMed ID: 806500
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
    Aghai E; Kende G; Many A; Ramot B
    Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination chemotherapy in advanced and recurrent Hodgkin's disease.
    McElwain TJ; Wrigley PF; Hunter A; Crowther D; Malpas JS; Peckham MJ; Smithers DW; Fairley GH
    Natl Cancer Inst Monogr; 1973 May; 36():395-402. PubMed ID: 4744597
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and hematological characteristics and MOPP tolerance of patients with Hodgkin's lymphoma in the bone marrow].
    Fiacchini M; Lauria F; Mazza P; Tura S
    Haematologica; 1982 Jun; 67(3):394-401. PubMed ID: 6814996
    [No Abstract]   [Full Text] [Related]  

  • 6. Long term experience with combination chemotherapy in advanced Hodgkin's disease.
    Garrett MJ; Das S; Smith JD; Freedman LS
    Clin Oncol; 1977 Jun; 3(2):145-54. PubMed ID: 68843
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of Hodgkin's disease.
    Desforges JF; Rutherford CJ
    Compr Ther; 1979 Feb; 5(2):63-9. PubMed ID: 428209
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experience with the management of patients with therapy-resistant Hodgkin's disease].
    Berényi E; Szegedi G
    Orv Hetil; 1984 Nov; 125(45):2737-40, 2743. PubMed ID: 6548560
    [No Abstract]   [Full Text] [Related]  

  • 9. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.
    Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R
    Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy of Hodgkin disease with modified MOPP].
    Amiel JL; Spielmann M; Kerbrat P; Droz JP; Tursz T; Ben Ayed F
    Schweiz Rundsch Med Prax; 1983 Feb; 72(6):190-3. PubMed ID: 6687638
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combined chemotherapy in Hodgkin's disease].
    Somers R; Haanen C; Hart AA; Kroese WF; Sizoo W; Wagener DJ
    Ned Tijdschr Geneeskd; 1976 Jun; 120(24):1038-43. PubMed ID: 1272447
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination chemotherapy and survival in advanced Hodgkin's disease.
    Canellos GP; Young RC; Berard CW; DeVita VT
    Arch Intern Med; 1973 Mar; 131(3):388-90. PubMed ID: 4569375
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Chemotherapy of Hodgkin's disease.
    Winokur SH
    N Engl J Med; 1974 Dec; 291(24):1309. PubMed ID: 4431438
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary treatment of disseminated Hodgkin's disease with BCNU alone and in combination with vincristine, procarbazine, and prednisone.
    Harrison DT; Neiman PE
    Cancer Treat Rep; 1977 Aug; 61(5):789-95. PubMed ID: 329978
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)].
    Neumann E
    Wien Klin Wochenschr; 1981 Feb; 93(4):134-7. PubMed ID: 6895134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent progress in the treatment of Hodgkin's disease].
    Jacquillat C
    Acquis Med Recent; 1977; ():89-98. PubMed ID: 910606
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission.
    Frei E; Luce JK; Gamble JF; Coltman CA; Constanzi JJ; Talley RW; Monto RW; Wilson HE; Hewlett JS; Delaney FC; Gehan EA
    Ann Intern Med; 1973 Sep; 79(3):376-82. PubMed ID: 4748254
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug therapy of Hodgkin's disease].
    Gallmeier WM; Bruntsch U
    Internist (Berl); 1981 May; 22(5):289-300. PubMed ID: 7019138
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
    Andrieu JM; Casassus P; Coscas Y; Darmont J; Goubeau C; Katz M; Jacquillat C; Tricot G; Weil M
    Bull Cancer; 1982; 69(4):321-9. PubMed ID: 6897520
    [No Abstract]   [Full Text] [Related]  

  • 20. People with Hodgkin disease: the nursing challenge.
    Le Blanc DH
    Nurs Clin North Am; 1978 Jun; 13(2):281-300. PubMed ID: 248744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.